Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy

This billing/coding guidance requires molecular biomarker testing for risk stratification of indeterminate pulmonary nodules following bronchoscopy to be billed with CPT 81479, using one unit of service and limited to a single billed test per patient. The DEX Z-Code identifier must be entered adjacent to the CPT code in specified claim fields for Part A and Part B (see Loop 2400/SV101-7/Item 19 for Part B; SV202-7/Block 80 for Part A) and the appropriate ICD-10-CM diagnosis code must be reported; do not add extra characters to the SV101-7 DEX Z-Code entry.

"Molecular biomarker testing for risk stratification of indeterminate pulmonary nodules following bronchoscopy."

Sign up to see full coverage criteria, indications, and limitations.